Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 2Melanoma 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Otorhinolaryngologic Neoplasms 1Neoplasm Metastasis 1Lip Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Cisplatin 52Radiotherapy 43Cetuximab 30Fluorouracil 27pembrolizumab 19Carboplatin 19Docetaxel 14Paclitaxel 8Radiotherapy, Intensity-Modulated 7Nivolumab 6Methotrexate 6Drug Therapy 6Surgical Procedures, Operative 5Chemotherapy, Adjuvant 5Radiation 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4nimotuzumab 3Taxes 3Chemoradiotherapy 3toripalimab 2lenvatinib 2epacadostat 2durvalumab 2dehydroftorafur 2camrelizumab 2avelumab 2advexin 2Specimen Handling 2Radiotherapy, Conformal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Squamous Cell Carcinoma of Head and Neck × Allovectin-7 × Clear all
NCT00050388 2008-06-24

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Vical

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases, Lip Neoplasms, Neoplasms, Otorhinolaryngologic Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡